OKG Capital

OKG Capital operates as a specialized venture capital firm, strategically investing in early-stage companies across the med-tech and life sciences sectors. The firm provides both capital and strategic guidance to high-impact businesses, focusing on innovative solutions that address significant clinical needs. Its structured approach aims to nurture advancements from development through market entry.

Established in 2018 and headquartered in Germany, OKG Capital was founded to address gaps in traditional investment for healthcare innovation. Karim Galzahr, the Managing Partner, leverages extensive finance experience and deep industry understanding. The firm’s inception stemmed from an insight into the need for dedicated capital and mentorship to accelerate critical medical advancements.

OKG Capital primarily serves emerging med-tech and life science companies seeking financial backing and strategic partnership. Its vision is to catalyze transformative advancements in healthcare, building a portfolio of companies that improve patient outcomes and contribute meaningfully to global health. The firm actively seeks ventures poised to redefine medical care.